Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rik Ossenkoppele

Showing results (251-260 of 295) with videos related to

Pageof 30
Sort By:
Nature Medicine|July 13, 2023
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's diseaseKanta Horie, Gemma Salvadó, Nicolas R Barthélemy, et al.
Neurology|September 25, 2023
Performance of a [<sup>18</sup>F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy BodiesEmma M Coomans, Lotte A de Koning, Roos M Rikken, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2021
The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individualsGemma Salvadó, Daniel Ferreira, Grégory Operto, et al.
Alzheimer'S Research & Therapy|March 6, 2025
TREM2 risk variants and associated endophenotypes in alzheimer's diseaseJanna I R Dijkstra, Lisa Vermunt, Vikram Venkatraghavan, et al.
Journal of Alzheimer'S Disease : JAD|May 14, 2023
Effects of the DICE Method to Improve Timely Recognition and Treatment of Neuropsychiatric Symptoms in Early Alzheimer's Disease at the Memory Clinic: The BEAT-IT StudyWillem S Eikelboom, Esther van den Berg, Michiel Coesmans, et al.
Nature Medicine|November 10, 2022
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive declineRik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
Brain : a Journal of Neurology|July 1, 2016
Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's diseaseGaël Chételat, Rik Ossenkoppele, Victor L Villemagne, et al.
Brain : a Journal of Neurology|March 9, 2023
Genetically identical twin-pair difference models support the amyloid cascade hypothesisEmma M Coomans, Jori Tomassen, Rik Ossenkoppele, et al.
Alzheimer'S Research & Therapy|October 19, 2024
The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU studyMarie R Vermeiren, Joost Somsen, Gert Luurtsema, et al.
Nature Medicine|April 9, 2025
Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platformSebastian Palmqvist, Noëlle Warmenhoven, Federica Anastasi, et al.
Pageof 30

Showing results (251-260 of 295) with videos related to

Sort By:
Pageof 30
Nature Medicine|July 13, 2023
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's diseaseKanta Horie, Gemma Salvadó, Nicolas R Barthélemy, et al.
Neurology|September 25, 2023
Performance of a [<sup>18</sup>F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy BodiesEmma M Coomans, Lotte A de Koning, Roos M Rikken, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2021
The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individualsGemma Salvadó, Daniel Ferreira, Grégory Operto, et al.
Alzheimer'S Research & Therapy|March 6, 2025
TREM2 risk variants and associated endophenotypes in alzheimer's diseaseJanna I R Dijkstra, Lisa Vermunt, Vikram Venkatraghavan, et al.
Journal of Alzheimer'S Disease : JAD|May 14, 2023
Effects of the DICE Method to Improve Timely Recognition and Treatment of Neuropsychiatric Symptoms in Early Alzheimer's Disease at the Memory Clinic: The BEAT-IT StudyWillem S Eikelboom, Esther van den Berg, Michiel Coesmans, et al.
Nature Medicine|November 10, 2022
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive declineRik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
Brain : a Journal of Neurology|July 1, 2016
Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's diseaseGaël Chételat, Rik Ossenkoppele, Victor L Villemagne, et al.
Brain : a Journal of Neurology|March 9, 2023
Genetically identical twin-pair difference models support the amyloid cascade hypothesisEmma M Coomans, Jori Tomassen, Rik Ossenkoppele, et al.
Alzheimer'S Research & Therapy|October 19, 2024
The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU studyMarie R Vermeiren, Joost Somsen, Gert Luurtsema, et al.
Nature Medicine|April 9, 2025
Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platformSebastian Palmqvist, Noëlle Warmenhoven, Federica Anastasi, et al.
Pageof 30